Drug Trial Radar · NCT07300839
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age
Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
5,240
Actual
Start
Dec 10, 2025
Primary completion
Sep 22, 2026
Study completion Sep 22, 2026
Sponsor
- Lead sponsor
- BioNTech SEIndustry
- Sponsor type
- Industry
- Collaborators
- Pfizer
- First posted
- Dec 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 64 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This study is designed to find out how well the COVID-19 vaccine protects people 50 to 64, who don't have any serious health problems, compared to a group that receives a vaccine that doesn't contain an ingredient to protect against COVID-19 (placebo).
Conditions
- COVID-19
- SARS-COV-2 Infection
Interventions
BNT162b2 VaccineBiological
Single dose
PlaceboBiological
Single dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of participants reporting local reactions or systemic eventsTime frame: From Day 1 up to 7 days after Vaccination
- Percentage of participants reporting adverse eventsTime frame: From Day 1 through 4 weeks after vaccination
- Percentage of participants reporting serious adverse eventsTime frame: From Day 1 through 6 months after vaccination
- First episode of confirmed COVID-19 casesTime frame: From 0 days after vaccination through end of COVID-19 surveillance at least 6 months post-vaccination
Locations
196 sites in 1 country. Site status is shown where the registry gives one.
Pinnacle Research Group, LLC
Anniston, Alabama
North Alabama Research Center
Athens, Alabama
Simon Williamson Clinic / Synexus Clinical Research US, Inc.
Birmingham, Alabama
Accel Research Sites - Birmingham Clinical Research Unit
Birmingham, Alabama
Cullman Clinical Trials
Cullman, Alabama
AMR Clinical
Daphne, Alabama
Medical Affiliated Research Center
Huntsville, Alabama
AMR Clinical
Mobile, Alabama
Chandler Clinical Trials
Chandler, Arizona
Scottsdale Clinical Trials
Scottsdale, Arizona
Epic Medical Research-Sun City
Sun City, Arizona
Noble Clinical Research
Tucson, Arizona
Synexus Clinical Research US, Inc./Orange Grove Family Practice
Tucson, Arizona
Woodland International Research Group, LLC
Little Rock, Arkansas
Anaheim Clinical Trials, LLC
Anaheim, California
Velocity Clinical Research, Chula Vista
Chula Vista, California
West Coast Research
Dublin, California
Triallogix Medical Corporation
Fullerton, California
Upper Echelon Medical
Fullerton, California
Marvel Clinical Research
Huntington Beach, California
Eximia Research-CA, LLC
La Mesa, California
Velocity Clinical Research, Los Angeles
Los Angeles, California
Leading Edge Research
Los Angeles, California
ImmuniMet
Modesto, California
Carbon Health - North Hollywood - NoHo West
North Hollywood, California
Empire Clinical Research
Pomona, California
Peninsula Research Associates
Rolling Hills Estates, California
Northern California Research - Sacramento
Sacramento, California
Velocity Clinical Research, San Bernardino
San Bernardino, California
Artemis Institute for Clinical Research
San Diego, California
Med Partners, Inc. dba Premiere Medical Center of Burbank, Inc.
Toluca Lake, California
Diablo Clinical Research, Inc.
Walnut Creek, California
Legacy Clinical Trials
Colorado Springs, Colorado
Tekton Research, LLC.
Fort Collins, Colorado
Tekton Research, LLC.
Longmont, Colorado
Paradigm Clinical Research Centers, LLC
Wheat Ridge, Colorado
Clinical Research Consulting
Milford, Connecticut
Stamford Therapeutics Consortium
Stamford, Connecticut
Washington Health Institute
Washington D.C., District of Columbia
International Clinical Research - FL, LLC
Altamonte Springs, Florida
Showing 40 of 196 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.